Radiation Therapy News and Research

RSS
Radiation therapy (also called radiotherapy, x-ray therapy, or irradiation) is the use of a certain type of energy (called ionizing radiation) to kill cancer cells and shrink tumors. Radiation therapy injures or destroys cells in the area being treated (the “target tissue”) by damaging their genetic material, making it impossible for these cells to continue to grow and divide. Although radiation damages both cancer cells and normal cells, most normal cells can recover from the effects of radiation and function properly. The goal of radiation therapy is to damage as many cancer cells as possible, while limiting harm to nearby healthy tissue.
No added risks to radiation therapy for cancer patients with COVID-19, says study

No added risks to radiation therapy for cancer patients with COVID-19, says study

Genomic and immune indicators can help identify prostate cancer patients at high risk of lethal outcomes

Genomic and immune indicators can help identify prostate cancer patients at high risk of lethal outcomes

Single-dose radiation therapy may lessen, eliminate unsafe additional outside trips during the pandemic

Single-dose radiation therapy may lessen, eliminate unsafe additional outside trips during the pandemic

Physicians don't always recognize radiation therapy side effects in cancer patients

Physicians don't always recognize radiation therapy side effects in cancer patients

Omitting postoperative radiation therapy did not compromise survival for older HR-positive breast cancer patients

Omitting postoperative radiation therapy did not compromise survival for older HR-positive breast cancer patients

Symptom under-recognition may be common in breast cancer patients treated with radiotherapy

Symptom under-recognition may be common in breast cancer patients treated with radiotherapy

Repair protein may prevent damage to healthy cells during cancer therapy

Repair protein may prevent damage to healthy cells during cancer therapy

Targeting senescent 'zombie' cells may improve survival in women with cervical cancer

Targeting senescent 'zombie' cells may improve survival in women with cervical cancer

First PSMA-targeted PET imaging drug approved for men with prostate cancer

First PSMA-targeted PET imaging drug approved for men with prostate cancer

Machine learning model identifies which drug combinations kill tumor cells

Machine learning model identifies which drug combinations kill tumor cells

Gut microbiota directly shapes the makeup of human immune system, shows study

Gut microbiota directly shapes the makeup of human immune system, shows study

Cost of prostate cancer treatment can be a major source of stress for men, their families

Cost of prostate cancer treatment can be a major source of stress for men, their families

Cell survival protein could protect kidneys from damage caused by cancer therapies

Cell survival protein could protect kidneys from damage caused by cancer therapies

Septic shock and pneumonia triggered by SARS-CoV-2 could be treated by radiation-activated MSCs

Septic shock and pneumonia triggered by SARS-CoV-2 could be treated by radiation-activated MSCs

Researchers assess the risk of proton therapy for children with brain tumors

Researchers assess the risk of proton therapy for children with brain tumors

IU researcher awarded NCI grant to develop a drug for making radiation therapy more effective

IU researcher awarded NCI grant to develop a drug for making radiation therapy more effective

Biodegradable 3D-printed esophageal stents for treating radiation esophagitis

Biodegradable 3D-printed esophageal stents for treating radiation esophagitis

High Throughput Identification and Quantification of Breast Cancer With NMR-Based Metabolomics

High Throughput Identification and Quantification of Breast Cancer With NMR-Based Metabolomics

High dose radiation therapy linked to shorter survival times in NSCLC patients

High dose radiation therapy linked to shorter survival times in NSCLC patients

Researchers report outcomes of salvage low dose RT brachytherapy after EBRT for prostate cancer

Researchers report outcomes of salvage low dose RT brachytherapy after EBRT for prostate cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.